Physician profile
Scott Diamond
NPI 1568992527
$7,318.88
in general payments reported to CMS, 2019-2025
14 companies · $37.10 in 2025
The $37.10 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $367 · 2021: $820 · 2022: $4,481 · 2023: $682 · 2024: $107 · 2025: $37.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $826.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,000.56 | 2019-2024 | Mako, Insignia, Triathlon |
| Zimmer Biomet Holdings, INC. | $387.47 | 2021-2022 | |
| Medtronic USA, INC. | $337.82 | 2019 | |
| Next Science LLC | $133.24 | 2023 | Surgx, Blastx, Xperience |
| Pacira Therapeutics, INC. | $104.98 | 2019 | |
| Medtronic, INC. | $100.50 | 2021-2024 | Intellis Adaptivestim |
| Sanara Medtech INC. | $54.12 | 2022 | |
| Si-Bone, INC. | $49.20 | 2022-2025 | |
| Pinnacle, INC | $42.38 | 2021 | |
| Medical Device Business Services, INC. | $40.87 | 2021 | |
| Biotissue Holdings INC. | $20.25 | 2025 | |
| Smith+Nephew, INC. | $18.13 | 2024 | Pico 7 |
| Ferring Pharmaceuticals INC. | $16.24 | 2024 | Euflexxa |
| Depuy Synthes Sales INC. | $13.12 | 2023 | Attune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Diamond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.